Viracta Therapeutics Company

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
Technology: Cancer, Tumor-Specific Antigens
Industry: Biopharma, Biotechnology, Medical, Pharmaceutical, Therapeutics
Headquarters: Cardiff By The Sea, California, United States
Founded Date: 2007-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 21
Total Funding: 184899999
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-11-05
Last Funding Type: Post-IPO Debt

Visit Website
info@viracta.com
https://twitter.com/ViractaT
Register and Claim Ownership